UCTRZAGWQCATCV-SFNQZPIRSA-N
C30H30ClF3N6O4 — CID 121455631
Data last refreshed: (MolForge compound catalog, from PubChem)
About UCTRZAGWQCATCV-SFNQZPIRSA-N
UCTRZAGWQCATCV-SFNQZPIRSA-N (PubChem CID 121455631) has the molecular formula C30H30ClF3N6O4 and a molecular weight of 631.06 g/mol. Its IUPAC name is trans-(1R,3S)-3-[8-amino-5-chloro-1-[2-ethoxy-4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-propan-2-ylcyclopentane-1-carboxylic acid.
Molecular Properties
| Compound Name | UCTRZAGWQCATCV-SFNQZPIRSA-N |
|---|---|
| PubChem CID | 121455631 |
| Molecular Formula | C30H30ClF3N6O4 |
| Molecular Weight | 631.06 g/mol |
| Exact Mass | 630.20 |
| IUPAC Name | trans-(1R,3S)-3-[8-amino-5-chloro-1-[2-ethoxy-4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-1-propan-2-ylcyclopentane-1-carboxylic acid |
| SMILES | CCOc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@H]2CC[C@](C(=O)O)(C(C)C)C2)n2c(Cl)cnc(N)c12 |
| InChI | InChI=1S/C30H30ClF3N6O4/c1-4-44-20-11-16(27(41)38-22-12-18(8-10-36-22)30(32,33)34)5-6-19(20)23-24-25(35)37-14-21(31)40(24)26(39-23)17-7-9-29(13-17,15(2)3)28(42)43/h5-6,8,10-12,14-15,17H,4,7,9,13H2,1-3H3,(H2,35,37)(H,42,43)(H,36,38,41)/t17-,29+/m0/s1 |
| InChIKey | UCTRZAGWQCATCV-SFNQZPIRSA-N |
| XLogP | 6.69 |
| TPSA | 144.73 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 631.06 |
| LogP ≤ 5 | 6.69 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121455631 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.